Poll: Will new technology bring a resurgence in enthusiasm for single port surgery?
Much innovation has taken place in the field of minimally invasive gynecologic surgery in the last decade. Enthusiasm for single-port surgery has waned over the past decade, due to factors like Reimbursement issues and technical demand led to a decrease in enthusiasm, but robotics companies continue to develop new solutions.
Robotics companies have developed solutions that enable minimally invasive gynecologic surgeons to triangulate instruments with greater ease.
In a recent roundtable, 4 renowned minimally invasive gynecologic surgeons discussed their experiences using novel vaginal natural orifice transluminal endoscopic surgery (vNOTES) technology. Watch the video here or listen on Contemporary OB/GYN®'s podcast Pap Talk.
Do you expect new technology, like vNOTES, to revive the industry's enthusiasm for single-port surgery?
FDA grants IND clearance to DARE-VVA1 for dyspareunia
December 7th 2023Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Read More
Treating heavy menstrual bleeding: Levonorgestrel system vs combined oral contraceptives
November 8th 2023In a recent study, patients who were treated for heavy menstrual bleeding with the levonorgestrel intrauterine system had similar changes in bleeding-related quality of life as those using combined oral contraceptives for treatment.
Read More
